Schwarzer Cardiotek receives FDA 510(k) clearance for software version 2
EP-TRACER - The Film
New User Reports about EP-TRACER Portable
Schwarzer Cardiotek presents software version 2 of its electrophysiogical measuring system EP-TRACER
Global medical technology company introduces new features for the improvement and simplification of electrophysiological examinations.
HEILBRONN, 17. December 2015 - Schwarzer Cardiotek announces the market introduction of the new software on their electrophysiological measurement system: EP-TRACER 2. The new features range from a simplified operability via refined representations of the signal types to improved analysis and reporting functions.
New Software - Outstanding Features
The EP TRACER 2 software offers an improved intuitive user interface, which supports the user’s needs at each stage of the examination. Special display modes, such as trigger mode, pressure mode and configurable split-screen modes offer excellent conditions for various types of signal in outstanding clarity: "For example, all surface and intracardiac ECG signals, invasive blood pressure and ablation data can be displayed in a customized layout. Also RF- and cryo-ablators are supported", explains Carsten Bienek, Director of R&D at Schwarzer Cardiotek.
Intuitive short cuts, e.g. to start and stop various types of stimulation of the fully integrated stimulator, promote the smooth operation of the EP-TRACER in the respective preferred workflows. They also enable the labeling and annotation of important events, which are added to the procedure log with time specification. In this way subsequent analysis is facilitated, which can take place from any point in the hospital network with a special review software.
"The consistent innovation of our products is the focus of the work of our development teams. With the EP-TRACER 2 software we achieved a genuine improvement in the clinical workflow", explains Dr. Michael Spaeth, President and Chief Operations Officer for Schwarzer Cardiotek.
About the EP-TRACER
The EP‐TRACER system is an electrophysiology measurement system used to acquire, filter, digitize, amplify, display, and record signals obtained during electrophysiological studies and related procedures. The compact, easy-to-use recording system provides superior signal clarity with a built-in dual channel programmable stimulator for electrophysiology (EP) studies. The EP-TRACER received CE- and FDA 510(k) clearance, the software version EP-TRACER 2 is CE-released (FDA 510(k) is pending). The system is commercially available in Europe, Central and South America, Asia Pacific and Middle East.
About Schwarzer Cardiotek
Schwarzer Cardiotek is a private medical technology company with a focus on electrophysiological and hemodynamic measurement systems and cardiology information systems. The company can look back on a 60-year-old tradition in the development and manufacture of polygraphical recording systems. Schwarzer Cardiotek relies on the overarching approach of creative thinking and collaboration with leading physicians and researchers from across the globe, to continually develop its products and stay at the cutting edge of technological innovation. For more information, see www.schwarzercardiotek.com.
Schwarzer Cardiotek GmbH
Director Marketing Communications
Phone +49 (0)7131 2774 500
Schwarzer Cardiotek concludes filling of key management-level positions
Philips und Schwarzer Cardiotek conclude reseller agreement for the cardiology information system cardWorks
Schwarzer GmbH, Heilbronn Germany, And Cardiotek B.V., Maastricht, The Netherlands Announces That The Two Companies Will Merge Under The New Brand Of Schwarzer Cardiotek
Cardiotek Announces U.S. Commercialization of the EP-Tracer System Company to Showcase the System at 2014 HRS Meeting